1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Retinal Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Gels 1.2.3 Ointments 1.2.4 Capsules & Tablets 1.2.5 Eye Drops 1.3 Market by Application 1.3.1 Global Retinal Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Macular Degeneration 1.3.3 Diabetic Retinopathy 1.3.4 Diabetic Macular Edema 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Retinal Disorders Treatment Market Perspective (2016-2027) 2.2 Retinal Disorders Treatment Growth Trends by Regions 2.2.1 Retinal Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Retinal Disorders Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Retinal Disorders Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Retinal Disorders Treatment Industry Dynamic 2.3.1 Retinal Disorders Treatment Market Trends 2.3.2 Retinal Disorders Treatment Market Drivers 2.3.3 Retinal Disorders Treatment Market Challenges 2.3.4 Retinal Disorders Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Retinal Disorders Treatment Players by Revenue 3.1.1 Global Top Retinal Disorders Treatment Players by Revenue (2016-2021) 3.1.2 Global Retinal Disorders Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Retinal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Retinal Disorders Treatment Revenue 3.4 Global Retinal Disorders Treatment Market Concentration Ratio 3.4.1 Global Retinal Disorders Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Treatment Revenue in 2020 3.5 Retinal Disorders Treatment Key Players Head office and Area Served 3.6 Key Players Retinal Disorders Treatment Product Solution and Service 3.7 Date of Enter into Retinal Disorders Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Retinal Disorders Treatment Breakdown Data by Type 4.1 Global Retinal Disorders Treatment Historic Market Size by Type (2016-2021) 4.2 Global Retinal Disorders Treatment Forecasted Market Size by Type (2022-2027) 5 Retinal Disorders Treatment Breakdown Data by Application 5.1 Global Retinal Disorders Treatment Historic Market Size by Application (2016-2021) 5.2 Global Retinal Disorders Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Retinal Disorders Treatment Market Size (2016-2027) 6.2 North America Retinal Disorders Treatment Market Size by Type 6.2.1 North America Retinal Disorders Treatment Market Size by Type (2016-2021) 6.2.2 North America Retinal Disorders Treatment Market Size by Type (2022-2027) 6.2.3 North America Retinal Disorders Treatment Market Size by Type (2016-2027) 6.3 North America Retinal Disorders Treatment Market Size by Application 6.3.1 North America Retinal Disorders Treatment Market Size by Application (2016-2021) 6.3.2 North America Retinal Disorders Treatment Market Size by Application (2022-2027) 6.3.3 North America Retinal Disorders Treatment Market Size by Application (2016-2027) 6.4 North America Retinal Disorders Treatment Market Size by Country 6.4.1 North America Retinal Disorders Treatment Market Size by Country (2016-2021) 6.4.2 North America Retinal Disorders Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Retinal Disorders Treatment Market Size (2016-2027) 7.2 Europe Retinal Disorders Treatment Market Size by Type 7.2.1 Europe Retinal Disorders Treatment Market Size by Type (2016-2021) 7.2.2 Europe Retinal Disorders Treatment Market Size by Type (2022-2027) 7.2.3 Europe Retinal Disorders Treatment Market Size by Type (2016-2027) 7.3 Europe Retinal Disorders Treatment Market Size by Application 7.3.1 Europe Retinal Disorders Treatment Market Size by Application (2016-2021) 7.3.2 Europe Retinal Disorders Treatment Market Size by Application (2022-2027) 7.3.3 Europe Retinal Disorders Treatment Market Size by Application (2016-2027) 7.4 Europe Retinal Disorders Treatment Market Size by Country 7.4.1 Europe Retinal Disorders Treatment Market Size by Country (2016-2021) 7.4.2 Europe Retinal Disorders Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Retinal Disorders Treatment Market Size (2016-2027) 8.2 Asia-Pacific Retinal Disorders Treatment Market Size by Type 8.2.1 Asia-Pacific Retinal Disorders Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Retinal Disorders Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Retinal Disorders Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Retinal Disorders Treatment Market Size by Application 8.3.1 Asia-Pacific Retinal Disorders Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Retinal Disorders Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Retinal Disorders Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Retinal Disorders Treatment Market Size by Region 8.4.1 Asia-Pacific Retinal Disorders Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Retinal Disorders Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Retinal Disorders Treatment Market Size (2016-2027) 9.2 Latin America Retinal Disorders Treatment Market Size by Type 9.2.1 Latin America Retinal Disorders Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Retinal Disorders Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Retinal Disorders Treatment Market Size by Type (2016-2027) 9.3 Latin America Retinal Disorders Treatment Market Size by Application 9.3.1 Latin America Retinal Disorders Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Retinal Disorders Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Retinal Disorders Treatment Market Size by Application (2016-2027) 9.4 Latin America Retinal Disorders Treatment Market Size by Country 9.4.1 Latin America Retinal Disorders Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Retinal Disorders Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Retinal Disorders Treatment Market Size (2016-2027) 10.2 Middle East & Africa Retinal Disorders Treatment Market Size by Type 10.2.1 Middle East & Africa Retinal Disorders Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Retinal Disorders Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Retinal Disorders Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Retinal Disorders Treatment Market Size by Application 10.3.1 Middle East & Africa Retinal Disorders Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Retinal Disorders Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Retinal Disorders Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Retinal Disorders Treatment Market Size by Country 10.4.1 Middle East & Africa Retinal Disorders Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Retinal Disorders Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan plc 11.1.1 Allergan plc Company Details 11.1.2 Allergan plc Business Overview 11.1.3 Allergan plc Retinal Disorders Treatment Introduction 11.1.4 Allergan plc Revenue in Retinal Disorders Treatment Business (2016-2021) 11.1.5 Allergan plc Recent Development 11.2 Bayer AG, F. 11.2.1 Bayer AG, F. Company Details 11.2.2 Bayer AG, F. Business Overview 11.2.3 Bayer AG, F. Retinal Disorders Treatment Introduction 11.2.4 Bayer AG, F. Revenue in Retinal Disorders Treatment Business (2016-2021) 11.2.5 Bayer AG, F. Recent Development 11.3 Hoffmann-La Roche Ltd. 11.3.1 Hoffmann-La Roche Ltd. Company Details 11.3.2 Hoffmann-La Roche Ltd. Business Overview 11.3.3 Hoffmann-La Roche Ltd. Retinal Disorders Treatment Introduction 11.3.4 Hoffmann-La Roche Ltd. Revenue in Retinal Disorders Treatment Business (2016-2021) 11.3.5 Hoffmann-La Roche Ltd. Recent Development 11.4 Graybug Vision, Inc. 11.4.1 Graybug Vision, Inc. Company Details 11.4.2 Graybug Vision, Inc. Business Overview 11.4.3 Graybug Vision, Inc. Retinal Disorders Treatment Introduction 11.4.4 Graybug Vision, Inc. Revenue in Retinal Disorders Treatment Business (2016-2021) 11.4.5 Graybug Vision, Inc. Recent Development 11.5 Kubota Pharmaceutical Holdings Co., Ltd. 11.5.1 Kubota Pharmaceutical Holdings Co., Ltd. Company Details 11.5.2 Kubota Pharmaceutical Holdings Co., Ltd. Business Overview 11.5.3 Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Introduction 11.5.4 Kubota Pharmaceutical Holdings Co., Ltd. Revenue in Retinal Disorders Treatment Business (2016-2021) 11.5.5 Kubota Pharmaceutical Holdings Co., Ltd. Recent Development 11.6 Novartis AG 11.6.1 Novartis AG Company Details 11.6.2 Novartis AG Business Overview 11.6.3 Novartis AG Retinal Disorders Treatment Introduction 11.6.4 Novartis AG Revenue in Retinal Disorders Treatment Business (2016-2021) 11.6.5 Novartis AG Recent Development 11.7 Regeneron Pharmaceuticals, Inc. 11.7.1 Regeneron Pharmaceuticals, Inc. Company Details 11.7.2 Regeneron Pharmaceuticals, Inc. Business Overview 11.7.3 Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Introduction 11.7.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Disorders Treatment Business (2016-2021) 11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development 11.8 Santen Pharmaceutical Co., Ltd. 11.8.1 Santen Pharmaceutical Co., Ltd. Company Details 11.8.2 Santen Pharmaceutical Co., Ltd. Business Overview 11.8.3 Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Introduction 11.8.4 Santen Pharmaceutical Co., Ltd. Revenue in Retinal Disorders Treatment Business (2016-2021) 11.8.5 Santen Pharmaceutical Co., Ltd. Recent Development 11.9 Takeda Pharmaceutical Company Limited 11.9.1 Takeda Pharmaceutical Company Limited Company Details 11.9.2 Takeda Pharmaceutical Company Limited Business Overview 11.9.3 Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Introduction 11.9.4 Takeda Pharmaceutical Company Limited Revenue in Retinal Disorders Treatment Business (2016-2021) 11.9.5 Takeda Pharmaceutical Company Limited Recent Development 11.10 Pfizer 11.10.1 Pfizer Company Details 11.10.2 Pfizer Business Overview 11.10.3 Pfizer Retinal Disorders Treatment Introduction 11.10.4 Pfizer Revenue in Retinal Disorders Treatment Business (2016-2021) 11.10.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Retinal Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Gels Table 3. Key Players of Ointments Table 4. Key Players of Capsules & Tablets Table 5. Key Players of Eye Drops Table 6. Global Retinal Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Retinal Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Retinal Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Retinal Disorders Treatment Market Share by Regions (2016-2021) Table 10. Global Retinal Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Retinal Disorders Treatment Market Share by Regions (2022-2027) Table 12. Retinal Disorders Treatment Market Trends Table 13. Retinal Disorders Treatment Market Drivers Table 14. Retinal Disorders Treatment Market Challenges Table 15. Retinal Disorders Treatment Market Restraints Table 16. Global Retinal Disorders Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Retinal Disorders Treatment Market Share by Players (2016-2021) Table 18. Global Top Retinal Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorders Treatment as of 2020) Table 19. Ranking of Global Top Retinal Disorders Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Retinal Disorders Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Retinal Disorders Treatment Product Solution and Service Table 23. Date of Enter into Retinal Disorders Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Retinal Disorders Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Retinal Disorders Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Retinal Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Retinal Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Retinal Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Retinal Disorders Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Retinal Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Retinal Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Retinal Disorders Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Retinal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Retinal Disorders Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Retinal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Retinal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Retinal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Retinal Disorders Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Retinal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Retinal Disorders Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Retinal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Retinal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Retinal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Retinal Disorders Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Retinal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Retinal Disorders Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Retinal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Retinal Disorders Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Retinal Disorders Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Retinal Disorders Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Retinal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Retinal Disorders Treatment Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Retinal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Retinal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Retinal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Retinal Disorders Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Retinal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Retinal Disorders Treatment Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Retinal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Retinal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Retinal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Allergan plc Company Details Table 64. Allergan plc Business Overview Table 65. Allergan plc Retinal Disorders Treatment Product Table 66. Allergan plc Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 67. Allergan plc Recent Development Table 68. Bayer AG, F. Company Details Table 69. Bayer AG, F. Business Overview Table 70. Bayer AG, F. Retinal Disorders Treatment Product Table 71. Bayer AG, F. Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 72. Bayer AG, F. Recent Development Table 73. Hoffmann-La Roche Ltd. Company Details Table 74. Hoffmann-La Roche Ltd. Business Overview Table 75. Hoffmann-La Roche Ltd. Retinal Disorders Treatment Product Table 76. Hoffmann-La Roche Ltd. Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 77. Hoffmann-La Roche Ltd. Recent Development Table 78. Graybug Vision, Inc. Company Details Table 79. Graybug Vision, Inc. Business Overview Table 80. Graybug Vision, Inc. Retinal Disorders Treatment Product Table 81. Graybug Vision, Inc. Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 82. Graybug Vision, Inc. Recent Development Table 83. Kubota Pharmaceutical Holdings Co., Ltd. Company Details Table 84. Kubota Pharmaceutical Holdings Co., Ltd. Business Overview Table 85. Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Product Table 86. Kubota Pharmaceutical Holdings Co., Ltd. Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 87. Kubota Pharmaceutical Holdings Co., Ltd. Recent Development Table 88. Novartis AG Company Details Table 89. Novartis AG Business Overview Table 90. Novartis AG Retinal Disorders Treatment Product Table 91. Novartis AG Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 92. Novartis AG Recent Development Table 93. Regeneron Pharmaceuticals, Inc. Company Details Table 94. Regeneron Pharmaceuticals, Inc. Business Overview Table 95. Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Product Table 96. Regeneron Pharmaceuticals, Inc. Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 97. Regeneron Pharmaceuticals, Inc. Recent Development Table 98. Santen Pharmaceutical Co., Ltd. Company Details Table 99. Santen Pharmaceutical Co., Ltd. Business Overview Table 100. Santen Pharmaceutical Co., Ltd. Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 101. Santen Pharmaceutical Co., Ltd. Recent Development Table 102. Takeda Pharmaceutical Company Limited Company Details Table 103. Takeda Pharmaceutical Company Limited Business Overview Table 104. Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Product Table 105. Takeda Pharmaceutical Company Limited Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 106. Takeda Pharmaceutical Company Limited Recent Development Table 107. Pfizer Company Details Table 108. Pfizer Business Overview Table 109. Pfizer Retinal Disorders Treatment Product Table 110. Pfizer Revenue in Retinal Disorders Treatment Business (2016-2021) & (US$ Million) Table 111. Pfizer Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Retinal Disorders Treatment Market Share by Type: 2020 VS 2027 Figure 2. Gels Features Figure 3. Ointments Features Figure 4. Capsules & Tablets Features Figure 5. Eye Drops Features Figure 6. Global Retinal Disorders Treatment Market Share by Application: 2020 VS 2027 Figure 7. Macular Degeneration Case Studies Figure 8. Diabetic Retinopathy Case Studies Figure 9. Diabetic Macular Edema Case Studies Figure 10. Others Case Studies Figure 11. Retinal Disorders Treatment Report Years Considered Figure 12. Global Retinal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Retinal Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Retinal Disorders Treatment Market Share by Regions: 2020 VS 2027 Figure 15. Global Retinal Disorders Treatment Market Share by Regions (2022-2027) Figure 16. Global Retinal Disorders Treatment Market Share by Players in 2020 Figure 17. Global Top Retinal Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorders Treatment as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Retinal Disorders Treatment Revenue in 2020 Figure 19. Global Retinal Disorders Treatment Revenue Market Share by Type (2016-2021) Figure 20. Global Retinal Disorders Treatment Revenue Market Share by Type (2022-2027) Figure 21. North America Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Retinal Disorders Treatment Market Share by Type (2016-2027) Figure 23. North America Retinal Disorders Treatment Market Share by Application (2016-2027) Figure 24. North America Retinal Disorders Treatment Market Share by Country (2016-2027) Figure 25. United States Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Retinal Disorders Treatment Market Share by Type (2016-2027) Figure 29. Europe Retinal Disorders Treatment Market Share by Application (2016-2027) Figure 30. Europe Retinal Disorders Treatment Market Share by Country (2016-2027) Figure 31. Germany Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Retinal Disorders Treatment Market Share by Type (2016-2027) Figure 39. Asia-Pacific Retinal Disorders Treatment Market Share by Application (2016-2027) Figure 40. Asia-Pacific Retinal Disorders Treatment Market Share by Region (2016-2027) Figure 41. China Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Retinal Disorders Treatment Market Share by Type (2016-2027) Figure 49. Latin America Retinal Disorders Treatment Market Share by Application (2016-2027) Figure 50. Latin America Retinal Disorders Treatment Market Share by Country (2016-2027) Figure 51. Mexico Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Retinal Disorders Treatment Market Share by Type (2016-2027) Figure 55. Middle East & Africa Retinal Disorders Treatment Market Share by Application (2016-2027) Figure 56. Middle East & Africa Retinal Disorders Treatment Market Share by Country (2016-2027) Figure 57. Turkey Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Retinal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Allergan plc Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 61. Bayer AG, F. Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 62. Hoffmann-La Roche Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 63. Graybug Vision, Inc. Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 64. Kubota Pharmaceutical Holdings Co., Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 65. Novartis AG Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 66. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 67. Santen Pharmaceutical Co., Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 68. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 69. Pfizer Revenue Growth Rate in Retinal Disorders Treatment Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Allergan plc Bayer AG, F. Hoffmann-La Roche Ltd. Graybug Vision, Inc. Kubota Pharmaceutical Holdings Co., Ltd. Novartis AG Regeneron Pharmaceuticals, Inc. Santen Pharmaceutical Co., Ltd. Takeda Pharmaceutical Company Limited Pfizer